1-甲基-2,5-二苯基-3,4-双（羟甲基）-、1,2,3-三苯基-4,5-双（羟甲基）-以及1-甲基-2,3-二苯基-4,5-双（羟甲基）吡咯双（N-甲基氨基甲酸酯）的合成及其抗白血病活性

1

J Med Chem. 1980 Jan;23(1):87-9. doi: 10.1021/jm00175a018.

2

J Med Chem. 1979 Aug;22(8):977-80. doi: 10.1021/jm00194a018.

3

J Pharm Sci. 1984 Aug;73(8):1182-3. doi: 10.1002/jps.2600730844.

4

J Med Chem. 1984 Dec;27(12):1559-65. doi: 10.1021/jm00378a006.

5

J Med Chem. 1987 Nov;30(11):2109-15. doi: 10.1021/jm00394a030.

6

J Med Chem. 1988 Nov;31(11):2097-102. doi: 10.1021/jm00119a008.

7

J Med Chem. 1984 Oct;27(10):1321-5. doi: 10.1021/jm00376a017.

8

J Med Chem. 1986 Nov;29(11):2241-9. doi: 10.1021/jm00161a019.

9

J Med Chem. 1989 Jan;32(1):119-27. doi: 10.1021/jm00121a023.

10

J Med Chem. 1986 Nov;29(11):2392-5. doi: 10.1021/jm00161a042.

Synthesis and antileukemic activity of 1-methyl-2,5-diphenyl-3,4-bis(hydroxymethyl)-, 1,2,3-triphenyl-4,5-bis(hydroxymethyl)-, and 1-methyl-2,3-diphenyl-4,5-bis(hydroxymethyl)pyrrole bis(N-methylcarbamate).